|
Status |
Public on Jan 31, 2024 |
Title |
Targeted proteomics analysis of Cutaneous Lupus Erythematosus patient interstitial skin fluid and plasma (Inflammation panel data) |
Organism |
Homo sapiens |
Experiment type |
Other
|
Summary |
We performed a targeted proteomics analysis of Cutaneous Lupus Erythematosus (CLE) patient blister biopsies and plasma using Olink Proteomics panels to validate the blister biopsy technique using previously identified biomarkers, to confirm protein-level expression of biomarkers previously identified at the RNA level, and to identify new biomarkers of disease.
|
|
|
Overall design |
Protein biomarkers in lesional and nonlesional interstitial skin fluid and blood plasma from 4 CLE patients and 3 healthy controls were measured using the Olink Proteomics Target 96 Inflammation panel v.3022.
|
|
|
Contributor(s) |
Richmond JM, Rashighi M |
Citation(s) |
38260617 |
|
Submission date |
Aug 17, 2021 |
Last update date |
Feb 08, 2024 |
Contact name |
Jillian M Richmond |
E-mail(s) |
jillian.richmond@umassmed.edu
|
Organization name |
UMass Chan Medical School
|
Department |
Dermatology
|
Street address |
364 Plantation St
|
City |
Worcester |
State/province |
Massachusetts |
ZIP/Postal code |
01605 |
Country |
USA |
|
|
Platforms (1) |
GPL30526 |
Target 96 Inflammation panel v.3022 |
|
Samples (38)
|
|
This SubSeries is part of SuperSeries: |
GSE182302 |
Targeted proteomics analysis of Cutaneous Lupus Erythematosus patient interstitial skin fluid and plasma |
|
Relations |
BioProject |
PRJNA755716 |